首页> 外文OA文献 >Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays
【2h】

Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays

机译:CYP2D6基因拷贝数的差异定量通过四种不同的实时荧光定量PCR检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Copy number variations (CNVs) in the CYP2D6 gene contribute to interindividual variation in drug metabolism. As the most common duplicated allele in Asian populations is the nonfunctional CYP2D6*36 allele, the goal of this study was to identify CNV assays that can differentiate between multiple copies of the CYP2D6*36 allele and multiple copies of other CYP2D6 alleles. We determined CYP2D6 gene copy numbers in 32 individuals with known CYP2D6 CNVs from the Coriell Japanese-Chinese panel using four quantitative real-time PCR assays. These assays target different regions of the CYP2D6 gene: 5'-flanking region, intron 2, intron 6, and exon 9 (Ex9). The specific target site of the Ex9 assay was verified by sequencing the PCR amplicon. Three of the CYP2D6 CNV assays (5'-flanking region, intron 2, and intron 6) estimated CYP2D6 copy numbers that were concordant for all 32 individuals. However, the Ex9 assay was concordant in only 10 of 32 samples. The 10 concordant samples did not contain any CYP2D6*36 alleles and the 22 discordant samples contained at least one CYP2D6*36 allele. In addition, the Ex9 assay accurately quantified all of the non-CYP2D6*36 alleles in all samples. Ex9 amplicon sequencing indicated that it targets a region of CYP2D6 exon 9 that undergoes partial gene-conversion in the CYP2D6*36 allele. In conclusion, CYP2D6 Ex9 CNV assay can be used to determine the copy number of non-CYP2D6*36 alleles. Selective amplification of non-CYP2D6*36 sequence by the Ex9 assay should be useful in determining the number of functional copies of CYP2D6 in Asian populations.
机译:CYP2D6基因的拷贝数变异(CNV)导致药物代谢的个体间变异。由于在亚洲人群中最常见的重复等位基因是非功能性CYP2D6 * 36等位基因,因此本研究的目标是鉴定可区分CYP2D6 * 36等位基因的多个拷贝与其他CYP2D6等位基因的拷贝的CNV分析。我们使用四种实时定量PCR分析方法,从Coriell日文-中文小组中确定了32名已知CYP2D6 CNV的个体中的CYP2D6基因拷贝数。这些测定法靶向CYP2D6基因的不同区域:5'侧翼区域,内含子2,内含子6和外显子9(Ex9)。通过对PCR扩增子进行测序,可以验证Ex9分析的特异性靶位点。 CYP2D6 CNV分析中的三种(5'侧翼区,内含子2和内含子6)估计CYP2D6拷贝数与所有32个人一致。但是,Ex9测定仅在32个样品中的10个中是一致的。 10个一致样本不包含任何CYP2D6 * 36等位基因,而22个不一致样本包含至少一个CYP2D6 * 36等位基因。此外,Ex9分析可准确定量所有样品中的所有非CYP2D6 * 36等位基因。 Ex9扩增子测序表明,它靶向CYP2D6 * 36等位基因中经历部分基因转化的CYP2D6外显子9区域。总之,CYP2D6 Ex9 CNV检测可用于确定非CYP2D6 * 36等位基因的拷贝数。通过Ex9分析选择性扩增非CYP2D6 * 36序列应有助于确定亚洲人群中CYP2D6的功能拷贝数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号